Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Zealand Pharma Ord Shs ZLDPF

Healthcare Biotechnology
Zealand Pharma A/S is a Denmark-based biotechnology company. The Company is focused on the discovery, design and development of peptide-based medicines for metabolic and gastrointestinal diseases and other rare disease areas with unmet medical needs. The Company's peptide-based product candidates includes clinical development, registration and, potentially, commercialization. Its pipeline... see more

Recent & Breaking News (PINL:ZLDPF)

Zealand Pharma receives first FDA approval and prepares for launch of Zegalogue® (dasiglucagon) injection

GlobeNewswire May 12, 2021

Zealand Pharma Hosts Conference Call on May 12 at 4 pm CET (10 am ET) to Present First Quarter Results for 2021

GlobeNewswire May 5, 2021

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

GlobeNewswire May 3, 2021

Zealand Pharma announces publication of Phase 3 trial evaluating efficacy and safety of dasiglucagon for treatment of severe hypoglycemia in adult patients with diabetes

GlobeNewswire May 3, 2021

Total number of shares and voting rights in Zealand Pharma at April 30, 2021

GlobeNewswire April 29, 2021

Boehringer Ingelheim and Zealand Pharma Advance to Phase 2 Clinical Testing in NASH and Obesity

GlobeNewswire April 13, 2021

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

GlobeNewswire April 9, 2021

Zealand Pharma increases its share capital as a consequence of exercise of employee warrants

GlobeNewswire April 9, 2021

Total number of shares and voting rights in Zealand Pharma at March 31, 2021

GlobeNewswire March 31, 2021

Zealand Pharma to participate in upcoming investor conferences

GlobeNewswire March 25, 2021

Zealand Pharma Announces FDA Approval of Zegalogue® (dasiglucagon) injection, for the Treatment of Severe Hypoglycemia in People with Diabetes

GlobeNewswire March 22, 2021

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

GlobeNewswire March 22, 2021

Zealand Pharma increases its share capital as a consequence of exercise of employee warrants

GlobeNewswire March 19, 2021

Zealand Pharma convenes its Annual General Meeting 2021

GlobeNewswire March 16, 2021

Zealand Pharma: on Track for Potential First Product Launch and Establishing Commercial Operations in the United States

GlobeNewswire March 11, 2021

Total number of shares and voting rights in Zealand Pharma at February 28, 2021

GlobeNewswire March 9, 2021

Zealand Pharma Virtual R&D Day Materials Now Available with Live Q&A Session on March 5, 2021

GlobeNewswire March 4, 2021

Zealand Pharma Hosts Conference Call on March 11 at 4 pm CET (10am ET) to Present Full Year Results for 2020

GlobeNewswire March 3, 2021

Zealand Pharma to participate in upcoming investor conferences

GlobeNewswire February 23, 2021

Zealand Pharma to participate in SVB Leerink 9th Annual Global Healthcare Conference

GlobeNewswire February 9, 2021